股票/基金 实时行情 股吧

简称:浙江医药 代码:600216


会计年度:2011-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
农业791,751.00261,540.00530,212.0066.97
医药工业3,509,694,600.001,779,427,445.001,730,267,156.0049.30
医药商业1,295,661,459.001,221,278,889.0074,382,570.005.74

会计年度:2011-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
动物营养产品1,030,316,948.00454,364,963.00575,951,984.4455.90
其他65,896,114.0063,294,742.002,601,372.393.95
人类营养产品497,392,396.00317,911,471.00179,480,925.7736.08
医药商业611,918,712.00576,965,558.0034,953,153.935.71
医药制造307,417,954.00174,056,061.00133,361,892.9943.38

会计年度:2010-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
原料药销售3,367,252,614.401,677,660,415.69----
制剂药销售1,175,061,184.41981,977,353.34----
农产品销售1,210,981.42438,148.18----
VA系列198,688,688.03155,891,793.9342,796,894.10--
β-胡萝卜素系列82,139,332.0752,896,957.3929,242,374.68--
合成VE系列2,199,075,087.37963,949,965.571,235,125,121.80--
天然VE系列123,024,991.04111,268,595.0511,756,395.99--
盐酸万古霉素系列139,735,169.6768,635,486.8771,099,682.80--

会计年度:2010-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
VA系列68,231,352.0045,689,518.0022,541,833.3633.04
β-胡萝卜素系列40,251,218.0026,088,933.0014,162,284.7735.18
合成VE系列1,190,723,550.00494,424,126.00696,299,424.3858.48
天然VE系列61,668,765.0056,387,364.005,281,401.178.56
盐酸万古霉素原料及制剂71,199,209.0037,864,420.0033,334,788.1146.82

会计年度:2009-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
VA系列199,671,840.37143,301,136.38----
β-胡萝卜素65,263,894.8941,972,198.33----
合成VE系列2,207,663,983.37925,512,729.62----
来立信系列121,303,444.5462,787,334.40----
天然VE系列106,914,348.90101,274,017.61----
盐酸万古霉素89,432,137.8658,420,395.60----

    5/9 转到